Nephrocare Health Services Limited (NSE:NEPHROPLUS)

Market Cap	60.96B
Revenue (ttm)	10.23B +134.0%
Net Income	768.40M
EPS	8.10
Shares Out	100.34M
PE Ratio	75.00
Forward PE	41.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	507,264
Average Volume	278,678
Open	589.90
Previous Close	585.45
Day's Range	589.90 - 618.75
52-Week Range	446.00 - 663.90
Beta	n/a
RSI	57.72
Earnings Date	May 19, 2026

About NSE:NEPHROPLUS

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2009
• Employees: 3,448
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NEPHROPLUS

Financial Performance

In fiscal year 2026, NSE:NEPHROPLUS's revenue was 10.23 billion, an increase of 35.40% compared to the previous year's 7.56 billion. Earnings were 768.40 million, an increase of 14.52%.